FindTrial
Sign In

Analysis of the results of TCT, HPV and DNA ploidy testing in cervical cancer screening

Analysis of the results of TCT, HPV and DNA ploidy testing in cervical cancer screening

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500103375
Enrollment
Unknown
Registered
2025-05-28
Start date
2023-06-16
Completion date
Unknown
Last updated
2025-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical cancer

Interventions

Gold Standard:Pathological results of cervical biopsy tissues under colposcopy
Index test:TCT HPV DNA ploidy detection

Sponsors

Shandong Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Not pregnant or termination of pregnancy more than 12 weeks; 2. No history of cervical and uterine treatment or surgery; 3. Intact cervix; 4. Patients and families are informed.This study was approved by the ethics committee of the hospital.

Exclusion criteria

Exclusion criteria: 1. Cervical cancer screening in recent 3 years; 2. Patients with malignant tumors of ovary, uterus and cervix; 3. When the woman is pregnant or lactating; 4. Patients with a history of radiotherapy and chemotherapy; 5. Combined with mental diseases.

Design outcomes

Primary

MeasureTime frame
Sensitivity;Specificity;Positive predictive value;Negative predictive value;—

Countries

China

Contacts

Public ContactFei Wang

Shandong Provincial Hospital

feiwangde@163.com+86 151 6886 3608

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026